A final House vote has been delayed for President Trump's second-term agenda on tax reductions, immigration enforcement and deep Medicaid cuts ...

Proteomics International is on the verge of releasing its groundbreaking PromarkerD diabetes blood test across the US, ahead of its global commercialisation.